Naftali Kaminski MD

Boehringer Ingelheim Pharmaceuticals, Inc. Professor of Medicine (Pulmonary); Section Chief (7/1/13 - present)

Departments & Organizations

Office of Student ResearchStem Cell Center, YaleCenter for RNA Science and Medicine, YaleInternal Medicine: Pulmonary, Critical Care & Sleep Medicine: Interstitial Lung Disease Program (ILD)

Research Interests

Genomics; microRNAs; Non-coding RNAs; Biomarkers; Idiopathic Pulmonary Fibrosis and other Interstitial Lung Disease; Advanced Lung Disease; Personalized Medicine; Systems Biology; High-throughput technologies; Matrix Mtealloproteases more...


  • B.M., Hebrew University, 1985
  • M.D., Hebrew University, 1989

Selected Publications

  • MicroRNA mimicry blocks pulmonary fibrosis. Montgomery RL, Yu G, Latimer PA, Stack C, Robinson K, Dalby CM, Kaminski N, van Rooij E. EMBO Mol Med. 2014 Sep 19;6(10):1347-56. doi: 10.15252/emmm.201303604.
  • Matrix metalloproteinase-19 promotes metastatic behavior in vitro and is associated with increased mortality in non-small cell lung cancer. Yu G, Herazo-Maya JD, Nukui T, Romkes M, Parwani A, Juan-Guardela BM, Robertson J, Gauldie J, Siegfried JM, Kaminski N, Kass DJ. Am J Respir Crit Care Med. 2014 Oct 1;190(7):780-90. doi: 10.1164/rccm.201310-1903OC.



Latest News


Edit Profile